Not surprising Allergan is getting acquired now, says Mizuho managing director
Published at : 19 Dec 2020
AbbVie is buying Allergan for $188.24 per share, at a premium of almost 45 percent. Mizuho analyst Irina Koffler joins 'Squawk Box' to discuss the merger and Allergan CEO's track record.
Squawk Box U.S.CNBCbusiness news